Literature DB >> 19661626

Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).

Richard J O'Brien1, Susan M Resnick, Alan B Zonderman, Luigi Ferrucci, Barbara J Crain, Olga Pletnikova, Gay Rudow, Diego Iacono, Miguel A Riudavets, Ira Driscoll, Donald L Price, Lee J Martin, Juan C Troncoso.   

Abstract

The Baltimore Longitudinal Study of Aging (BLSA) was established in 1958 and is one the oldest prospective studies of aging in the USA and the world. The BLSA is supported by the National Institute of Aging (NIA) and its mission is to learn what happens to people as they get old and how to sort out changes due to aging from those due to disease or other causes. In 1986, an autopsy program combined with comprehensive neurologic and cognitive evaluations was established in collaboration with the Johns Hopkins University Alzheimer's Disease Research Center (ADRC). Since then, 211 subjects have undergone autopsy. Here we review the key clinical neuropathological correlations from this autopsy series. The focus is on the morphological and biochemical changes that occur in normal aging, and the early neuropathological changes of neurodegenerative diseases, especially Alzheimer's disease (AD). We highlight the combined clinical, pathologic, morphometric, and biochemical evidence of asymptomatic AD, a state characterized by normal clinical evaluations in subjects with abundant AD pathology. We conclude that in some individuals, successful cognitive aging results from compensatory mechanisms that occur at the neuronal level (i.e., neuronal hypertrophy and synaptic plasticity) whereas a failure of compensation may culminate in disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661626      PMCID: PMC2978421          DOI: 10.3233/JAD-2009-1179

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.

Authors:  C I Sze; H Bi; B K Kleinschmidt-DeMasters; C M Filley; L J Martin
Journal:  J Neurol Sci       Date:  2000-04-15       Impact factor: 3.181

3.  Risk of dementia in Parkinson's disease: a community-based, prospective study.

Authors:  D Aarsland; K Andersen; J P Larsen; A Lolk; H Nielsen; P Kragh-Sørensen
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

4.  The morphological basis of mental dysfunction in Parkinson's disease.

Authors:  K A Jellinger
Journal:  J Neurol Sci       Date:  2006-06-23       Impact factor: 3.181

Review 5.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

6.  An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease.

Authors:  Y Stern; D Jacobs; J Goldman; E Gomez-Tortosa; B T Hyman; Y Liu; J Troncoso; K Marder; M X Tang; J Brandt; M Albert
Journal:  Arch Neurol       Date:  2001-03

7.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors: 
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

8.  Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

Authors:  C Kawas; S Gray; R Brookmeyer; J Fozard; A Zonderman
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

9.  Effect of infarcts on dementia in the Baltimore longitudinal study of aging.

Authors:  Juan C Troncoso; Alan B Zonderman; Susan M Resnick; Barbara Crain; Olga Pletnikova; Richard J O'Brien
Journal:  Ann Neurol       Date:  2008-08       Impact factor: 10.422

Review 10.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

View more
  63 in total

Review 1.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

2.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

Review 3.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

Review 4.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

Review 5.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

Review 6.  Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

Authors:  S Negash; D A Bennett; R S Wilson; J A Schneider; S E Arnold
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

Review 7.  Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?

Authors:  I Driscoll; J Troncoso
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

8.  Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles.

Authors:  Julia Kim; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jul-Sep       Impact factor: 2.703

9.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

10.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.